| Style | Citing Format |
|---|---|
| MLA | Elsayed ZA, et al.. "X-Linked Agammaglobulinemia (Xla):Phenotype, Diagnosis, and Therapeutic Challenges Around the World." World Allergy Organization Journal, vol. 12, no. 3, 2019, pp. -. |
| APA | Elsayed ZA, Abramova I, Aldave JC, Alherz W, Bezrodnik L, Boukari R, Bousfiha AA, Cancrini C, Condinoneto A, Dbaibo G, Derfalvi B, Dogu F, Edgar JDM, Eley B, Elowaidy RH, Espinosapadilla SE, Galal N, Haerynck F, Hannawakim R, ... Sullivan KE (2019). X-Linked Agammaglobulinemia (Xla):Phenotype, Diagnosis, and Therapeutic Challenges Around the World. World Allergy Organization Journal, 12(3), -. |
| Chicago | Elsayed ZA, Abramova I, Aldave JC, Alherz W, Bezrodnik L, Boukari R, Bousfiha AA, et al.. "X-Linked Agammaglobulinemia (Xla):Phenotype, Diagnosis, and Therapeutic Challenges Around the World." World Allergy Organization Journal 12, no. 3 (2019): -. |
| Harvard | Elsayed ZA et al. (2019) 'X-Linked Agammaglobulinemia (Xla):Phenotype, Diagnosis, and Therapeutic Challenges Around the World', World Allergy Organization Journal, 12(3), pp. -. |
| Vancouver | Elsayed ZA, Abramova I, Aldave JC, Alherz W, Bezrodnik L, Boukari R, et al.. X-Linked Agammaglobulinemia (Xla):Phenotype, Diagnosis, and Therapeutic Challenges Around the World. World Allergy Organization Journal. 2019;12(3):-. |
| BibTex | @article{ author = {Elsayed ZA and Abramova I and Aldave JC and Alherz W and Bezrodnik L and Boukari R and Bousfiha AA and Cancrini C and Condinoneto A and Dbaibo G and Derfalvi B and Dogu F and Edgar JDM and Eley B and Elowaidy RH and Espinosapadilla SE and Galal N and Haerynck F and Hannawakim R and Hossny E and Ikinciogullari A and Kamal E and Kanegane H and Kechout N and Lau YL and Morio T and Moschese V and Neves JF and Ouederni M and Paganelli R and Paris K and Pignata C and Plebani A and Qamar FN and Qureshi S and Radhakrishnan N and Rezaei N and Rosario N and Routes J and Sanchez B and Sediva A and Seppanen MR and Serrano EG and Shcherbina A and Singh S and Siniah S and Spadaro G and Tang M and Vinet AM and Volokha A and Sullivan KE}, title = {X-Linked Agammaglobulinemia (Xla):Phenotype, Diagnosis, and Therapeutic Challenges Around the World}, journal = {World Allergy Organization Journal}, volume = {12}, number = {3}, pages = {-}, year = {2019} } |
| RIS | TY - JOUR AU - Elsayed ZA AU - Abramova I AU - Aldave JC AU - Alherz W AU - Bezrodnik L AU - Boukari R AU - Bousfiha AA AU - Cancrini C AU - Condinoneto A AU - Dbaibo G AU - Derfalvi B AU - Dogu F AU - Edgar JDM AU - Eley B AU - Elowaidy RH AU - Espinosapadilla SE AU - Galal N AU - Haerynck F AU - Hannawakim R AU - Hossny E AU - Ikinciogullari A AU - Kamal E AU - Kanegane H AU - Kechout N AU - Lau YL AU - Morio T AU - Moschese V AU - Neves JF AU - Ouederni M AU - Paganelli R AU - Paris K AU - Pignata C AU - Plebani A AU - Qamar FN AU - Qureshi S AU - Radhakrishnan N AU - Rezaei N AU - Rosario N AU - Routes J AU - Sanchez B AU - Sediva A AU - Seppanen MR AU - Serrano EG AU - Shcherbina A AU - Singh S AU - Siniah S AU - Spadaro G AU - Tang M AU - Vinet AM AU - Volokha A AU - Sullivan KE TI - X-Linked Agammaglobulinemia (Xla):Phenotype, Diagnosis, and Therapeutic Challenges Around the World JO - World Allergy Organization Journal VL - 12 IS - 3 SP - EP - PY - 2019 ER - |